QA: AbbVie Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2023_AbbVie_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001551152, AbbVie Inc.

  xvar xval
0 AssetsCurrent 28,463,000,000
1 IntangibleAssetsNetIncludingGoodwill 99,595,000,000
2 PropertyPlantAndEquipmentNet 4,935,000,000
3 remainder_Assets 5,812,000,000
4 LiabilitiesCurrent 29,538,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 17,414,000,000
8 SellingGeneralAndAdministrativeExpense 15,260,000,000
9 ResearchAndDevelopmentExpense 7,207,000,000
10 remainder_Expenses 1,688,000,000
11 remainder_Revenues 58,054,000,000
12 remainder_NetIncome -4,640,000,000
13 remainder_ComprehensiveNetIncome 691,000,000
  yvar yval
0 Assets 138,805,000,000
1 Liabilities 29,538,000,000
2 Expenses 41,569,000,000
3 Revenues 58,054,000,000
4 StockholdersEquity 109,267,000,000
5 NetIncome 11,845,000,000
6 ComprehensiveNetIncome 12,190,500,000
7 BaseVar 136,648,500,000
8 EconomicCapitalRatio 2.38

Edgar->Model Mapping

Feature Distribution

Change over Time